Payments to medical institutions and healthcare professionals

Transparency Guidelines

A. Research and development expenses, etc.

Research and development expenses, etc., include expenses incurred for research and investigations conducted under public regulations such as the Clinical Research Act and the GCP/GVP/GPSP Ministerial Ordinance in the Pharmaceuticals and Medical Devices Act, as well as various guidelines.

Disclosure Items Disclosure Details
A1 Specific clinical research expenses (Note 1) Name of facility, etc. to be provided (Note 2): XX cases, XX yen
A2 Research expenses based on ethical guidelines (Note 3) Name of facility, etc. to be provided (Note 4): XX cases, XX yen
A3 Non-clinical research expenses (Note 5) Name of the facility, etc. to which the information is provided
A4 clinical trial costs Name of facility, etc. to be provided (Note 4): XX cases, XX yen
A5 Post-marketing clinical trial expenses Name of facility, etc. to be provided (Note 4): XX cases, XX yen
A6 Adverse drug reaction and infection case report fee Name of facility, etc. to be provided (Note 4): XX cases, XX yen
A7 Post-marketing surveillance expenses Name of facility, etc. to be provided (Note 4): XX cases, XX yen
A8 Other Expenses Total annual amount
  • Specified Clinical Research Expenses" means expenses paid under the Specified Clinical Research Agreement as defined in the Clinical Research Act.
  • The "clinical research identification number," "funding source," "name of the general manager," "name of the medical institution conducting the research," "name of the principal investigator," etc. will be made public.
  • The term "ethical guidelines" in "research expenses based on ethical guidelines" refers to the "Ethical Guidelines for Life Sciences and Medical Research Involving Human Subjects.
  • The name of the facility, the name of the organization within the facility, and the affiliation, title, and name of the individual will be disclosed in accordance with the terms of the contract.
  • Non-clinical research expenses" refers to research other than specific clinical research, research based on ethical guidelines, clinical trials, and post-marketing surveillance, etc., and includes expenses spent for so-called "basic research" and "formulation-based research.

B. Academic Research Grants

Scholarship donations and general donations made for the purpose of promoting academic research and subsidizing research, etc., as well as donations to academic societies, etc., to support the costs of holding meetings of academic societies, etc., and expenses for co-sponsoring academic societies, etc.
The "co-sponsorship fees for conferences, etc." include co-sponsorship fees for seminars, etc., advertising fees, exhibition fees, etc., incidental to the holding of the meeting.

Disclosure Items Disclosure Details
B1 scholarship endowment XX University, XX Department: XX cases, XX yen
B2 General Donations XX University (XX Foundation): XX cases, XX yen
B3 Contributions from academic societies, etc. The XXth XX Conference (XXth Regional Meeting and XXth Study Group): XX yen
B4 Expenses for co-sponsoring academic conferences, etc. The XXth XX academic conference XX seminar: XX yen

C. Manuscript writing fees, etc.

Fees paid for the provision of scientific information on medical and pharmaceutical sciences, including the company's own pharmaceutical products, or for outsourcing services such as lectures, manuscript writing, supervision, and other consulting services related to research and development.

Disclosure Items Disclosure Details
C1 Lecturer gratuities XX University (XX Hospital), XX Department, XX Professor (Head of Department): XX cases, XX yen
C2 Manuscript writing and supervision fees XX University (XX Hospital), XX Department, XX Professor (Head of Department): XX cases, XX yen
C3 Consulting and other outsourcing expenses XX University (XX Hospital), XX Department, XX Professor (Head of Department): XX cases, XX yen

D. Information provision-related expenses

Expenses for lectures, information meetings, etc., to provide information, etc., on the company's pharmaceuticals and medical and pharmaceutical sciences to medical professionals.

Disclosure Items Disclosure Details
D1 Lecture and other meeting expenses Number of cases and total amount per year
D2 Briefing fee Number of cases and total amount per year
D3 Medical and pharmaceutical literature provision expenses Total annual amount

E. Other Expenses

Expenses such as hospitality as a social ritual.

Disclosure Items Disclosure Details
E1 Hospitality Expenses Total annual amount

Rules of Use

In order to use the information we disclose regarding "payments to medical institutions and other healthcare providers", you must agree to the following rules of use. Please read the following Terms of Use and click the "Agree" button to proceed. By clicking the "Agree" button, you agree that you have read and accepted the Terms of Use.

Usage Rules

Payments to Medical Institutions and Medical Professionals" is to disclose this information in an effort to make it easier to understand that we are working together to contribute to the development of medical and pharmaceutical sciences in a proper relationship with medical institutions, etc., and to contribute to the development of medical and pharmaceutical sciences, in compliance with the spirit of the legal rules, pharmaceutical organization rules, our rules, and other rules and the concept of law ("justice" and "stability"), and that we are also working together with medical institutions, etc. in a proper relationship with medical institutions, etc. We are disclosing this information in an effort to provide an easy-to-understand understanding of our relationship with medical institutions.

Prohibited items

Users of this information ("Users") are prohibited from engaging in any of the following or similar activities

  • Other than viewing this information, regardless of who you are.
  • Falsifying or deleting/destroying this information, etc.
  • Interfering with the purpose of disclosure, such as by blocking access to this information
  • Moving the Information from the Company's website, unauthorized posting of the Information by modification or processing, copying, reproduction, transcription, reprinting, transmission, or posting on social networks (electronic bulletin boards, etc.).
  • Infringing on the property, rights, interests, or privacy of medical institutions and their employees, medical personnel, etc., our company (including our employees), or any other person
  • Defaming or slandering medical institutions, medical personnel, our company (including our employees), or any person.
  • Damaging the credibility of medical institutions, medical personnel, etc., our company (including our employees), or any person
  • Causing damage to medical institutions, medical personnel, etc., our company (including our employees), or any person
  • Hazardous acts and adverse events, crimes, and things related to or connected with crimes
  • Violation of legal norms
  • Any action that the Company deems offensive to public order and morals

Disclaimer of Liability

We will use our best efforts to promptly repair any problems that may occur in the use of our website, such as access problems or discrepancies in the Information.

Under no circumstances will the Company be liable for any damages incurred by you or any other person as a result of any failure to access this information.

Regardless of the accuracy of the Information, the Company shall not be liable for any damages incurred by users or third parties resulting from the viewing or use of the Information.

Change, Suspension, or Cessation of Disclosure

We reserve the right to change or delete the content of this information as necessary or as required by our circumstances without prior notice.

We reserve the right to suspend or discontinue the disclosure of this information without notice in the event of maintenance, updating, or emergency of this site, or in the event that the continued operation of this site becomes difficult due to force majeure such as fire, power outages, natural disasters, or other unforeseen circumstances.

The Company shall be exempt from responsibility for any disadvantage or damage incurred by users or related parties due to changes in the above content, interruption or suspension of disclosure, etc.

Changes to the Rules of Use, etc.

The Company reserves the right to change the Rules of Use at any time without notice. If you or any related person accesses our Web site after the change of the Rules of Use, you will be deemed to have accepted the revised Rules of Use.

governing law

The laws of Japan shall apply to the formation, validity, performance, and interpretation of these Terms of Use.